Search Results - "Jimenez, Heidy"
-
1
Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity
Published in PloS one (29-04-2013)“…The use of antibodies to treat neurodegenerative diseases has undergone rapid development in the past decade. To date, immunotherapeutic approaches to…”
Get full text
Journal Article -
2
Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice
Published in PloS one (09-08-2023)“…Advances in tau biology and the difficulties of amyloid-directed immunotherapeutics have heightened interest in tau as a target for small molecule drug…”
Get full text
Journal Article -
3
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
Published in Molecular medicine (Cambridge, Mass.) (20-07-2022)“…BackgroundExposure to anesthesia in the elderly might increase the risk of dementia. Although the mechanism underlying the association is uncertain, anesthesia…”
Get full text
Journal Article -
4
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
Published in PloS one (13-08-2015)“…Recent work from our lab and few others have strongly suggested that immunotherapy could be an effective means of preventing the development of tau…”
Get full text
Journal Article -
5
In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice
Published in Journal of Alzheimer's disease (01-01-2020)“…Tau oligomers have been shown to transmit tau pathology from diseased neurons to healthy neurons through seeding, tau misfolding, and aggregation that is…”
Get more information
Journal Article -
6
The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [11C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease
Published in Biomedicines (25-07-2023)“…Psychosis that occurs over the course of Alzheimer’s disease (AD) is associated with increased caregiver burden and a more rapid cognitive and functional…”
Get full text
Journal Article -
7
The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease
Published in Alzheimer's & dementia : translational research & clinical interventions (2022)“…Introduction Psychosis in Alzheimer's disease (AD) is associated with grave clinical consequences including a precipitous cognitive decline and a hastened…”
Get full text
Journal Article -
8
CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease
Published in Molecular medicine (Cambridge, Mass.) (01-01-2013)“…The endocannabinoid CB₂ receptor system has been implicated in the neuropathology of Alzheimer's disease (AD). In order to investigate the impact of the CB₂…”
Get full text
Journal Article -
9
Tau release from hTau mouse primary neuronal cultures
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
10
-
11
In vivo validation of a lead compound targeting tau self‐association in two mouse models of tauopathy
Published in Alzheimer's & dementia (01-12-2020)“…Background Tau self‐association is the initial step in the formation of toxic tau oligomers and larger aggregates. Our program is highly differentiated in that…”
Get full text
Journal Article -
12
CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease
Published in Molecular medicine (Cambridge, Mass.) (14-03-2014)“…The endocannabinoid CB2 receptor system has been implicated in the neuropathology of Alzheimer's disease (AD). In order to investigate the impact of the CB2…”
Get full text
Journal Article -
13
Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT‐deleted (DM) tau mouse model
Published in Journal of neurochemistry (01-01-2019)“…In Alzheimer's disease, the phosphorylation of tau is a critical event preceding the formation of neurofibrillary tangles. Previous work exploring the impact…”
Get full text
Journal Article -
14
In vivo validation of therapeutic efficacy of a small molecule lead targeting tau self‐association in JNPL3 mice
Published in Alzheimer's & dementia (01-12-2021)“…Background Small molecules were screened and optimized for inhibiting tau self‐association, the initial step in the formation of soluble toxic tau oligomers…”
Get full text
Journal Article -
15
LINEAR DOSE-DEPENDENT INHIBITION OF TAU AGGREGATION IN VIVO WITH SMALL MOLECULE
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
16
P4‐698: LINEAR DOSE‐DEPENDENT INHIBITION OF TAU AGGREGATION IN VIVO WITH SMALL MOLECULE
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
17
IN VIVO EFFICACY OF A SMALL MOLECULE INHIBITOR OF TAU OLIGOMER FORMATION IN HTAU MICE
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
18
P4‐222: IN VIVO EFFICACY OF A SMALL MOLECULE INHIBITOR OF TAU OLIGOMER FORMATION IN HTAU MICE
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
19
The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [[sup.11]C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease
Published in Biomedicines (01-07-2023)“…Psychosis that occurs over the course of Alzheimer’s disease (AD) is associated with increased caregiver burden and a more rapid cognitive and functional…”
Get full text
Journal Article -
20
Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities
Published in Neurobiology of aging (01-09-2014)“…Abstract Converging evidence suggests that psychotic Alzheimer's disease (AD + P) is associated with an acceleration of frontal degeneration, with tau…”
Get full text
Journal Article